PDF of Woessner Representative Issued Patents
Representative Issued Patents Drafted and/or Prosecuted by Warren D. Woessner
Pharmaceuticals, Biologicals
Genes and Gene Therapy
Microorganisms/Cell Culture Technology/Stem Cells
Monoclonal Antibodies and Diagnostic Methods
Enzymology
Polypeptides
Agricultural Biotechnology
Methods of Medical Treatment
Drug Delivery Systems
Medical Devices
DNA Isolation and Synthesis
Vaccines
Pharmaceuticals, Biologicals
Poniard Pharmaceuticals, Inc. (U.S. Pat. No. 7,696,331): HIGH-DOSE RADIONUCLIDE COMPLEXES
Genzyme Corp. (U.S. RE41,209E): PLATINUM COMPLEXES
Orphan Medical, Inc. (U.S. Pat. No. 7,572,605): GAMMA-HYDROXYBUTYRATE COMPOSITIONS
Orphan Medical, Inc. (U.S. Pat. No. 7,262,219): GAMMA-HYDROXY BUTYRATE FOR THE TREATMENT OF NARCOLEPSY
University of California (U.S. Pat. No. 7,141,603): ANTITUMOR AGENTS
Aesgen, Inc. (U.S. Pat. No. 6,211,169): STABLE CALCITRIOL SOLUTION FOR PACKAGING INTO VIALS
University of Minnesota (U.S. Pat. No. 6,534,512): DIDEOXYCARBOCYCLIC NUCLEOSIDES
University of Minnesota (U.S. Pat. No. 5,929,087): DECAHYDROQUINOLINE-BASED ANTI-CHOLINERGIC AGENTS
Mayo Clinic (U.S. Patent No. 5,783,584): THA ANALOGS USEFUL AS CHOLINESTERASE INHIBITORS
Research Corp. Technologies (U.S. Patent No. 5,840,859): (AMINOSTYRYL) PYRIDIUM COMPOUNDS FOR RADIOLABELLING CELL MEMBRANES
Research Corp. Technologies (U.S. Patent No. 5,648,378): 2-IMINOCHROMENE DERIVATIVES AS INHIBITORS OF PTK
Genes and Gene Therapy
Mayo Clinic/Hybritech, Inc. (U.S. Pat. No. 6,013,471): DNA ENCODING VARIANT HK2 POLYPEPTIDES.
Mayo Clinic (U.S. Patent No. 5,470,737): STABLY-TRANSFORMED CELLS EXPRESSING HUMAN THIOPURINE METHYLTRANSFERASE
Mayo Clinic (U.S. Patent No. 5,744,355): CLONING AND EXPRESSION OF HUMAN LIVER ESTROGEN TRANSFERASE
Mayo Clinic (U.S. Patent 5,618,695): DNA ENCODING HEM-1
University of Minnesota (U.S. Pat. No. 6,238,916): DNA ENCODING TURKEY HYPOTHALMIC VASOACTIVE INTESTINAL PEPTIDE
University of Rochester (U.S. Patent 5,601,818): CANCER THERAPY UTILIZING MALIGNANT CELLS EXPRESSING HSV-TK
Microorganisms/Cell Culture Technology/Stem Cells
University of Minnesota (U.S. Pat. No. 7,015,037): MULTIPOTENT STEM CELLS AND METHODS FOR ISOLATION
University of Minnesota (U.S. Pat. No. 6,277,557): INFUSIBLE GRADE SHORT-TERM CELL STORAGE MEDIUM
U of Minnesota (U.S. Patent No. 5,460,964): METHOD FOR CULTURING HEMATOPOIETIC CELLS
U of Minnesota (U.S. Patent No. 5,436,151): METHOD FOR CULTURING HUMAN HEMATOPOIETIC STEM CELLS IN VITRO
Mayo Clinic (U.S. Patent No. 5,693,511): IMMORTALIZED HUMAN FETAL OSTEOBLASTIC CELLS
Monoclonal Antibodies and Diagnostic Methods
University of Arkansas (U.S. Pat. No. 7,601,800): COMPOSITIONS AND METHODS FOR MONITORING BREAST CANCER TREATMENT
Research Corporation Technologies, Inc.(U. S. Pat. No. 6,106,834): USE OF ANTI-CD45 LEUKOCYTE ANTIGEN ANTIBODIES FOR IMMUNOMODULATION.
University of Minnesota (U.S. Pat. No. 5,919,457): TXU-5/B53-APA ANTIVIRAL THERAPEUTIC AGENT FOR THE TREATMENT OF AIDS.
Mayo Clinic (U.S. Pat. No 5,827,497): CHARCOAL – RADIONUCLIDE AGENTS FOR MEASUREMENT OF GASTROINTESTINAL TRANSIT.
Mayo Clinic (U.S. Patent No. 5,529,902): DIRECT FLUORESCENCE-CONJUGATED IMMUNOASSAY FOR PLATELET ACTIVATION
NeoRx (U.S. Patent No. 5,545,569): METHODS TO DETERMINE TGF-BETA
U of Minnesota (U.S. Patent No. 5,316,907): ENZYMATIC FLUOROMETRIC ASSAY FOR ADENYLATE CYCLASE
Mayo Clinic (U.S. Patent No. 5,516,639): ANTIBODIES SPECIFIC FOR HUMAN PROSTATE GLANDULAR KALLIKREIN
Mayo Clinic (U.S. Pat. No. 6,087,097): PCR DETECTION OF BORRELIA BURGDORFERI
Enzymology
Iowa State University (U.S. Pat. No. 5,804,426): RECOMBINANT CYCLODEXTRAN GLUCANOTRANSFERASE MUTANTS
Research Corporations Technologies (U.S. Patent No. 5,728,804): USE OF CYCLODEXTRINS FOR PROTEIN RENATURATION
Iowa State (U.S. Patent No. 5,804,426): RECOMBINANT CYCLODEXTRAN GLUCANOTRANSFERASE MUTANTS
Polypeptides
University of Missouri (U.S. Pat. No. 7,214,664): PEPTIDE PRO-DRUGS THAT RESIST P-GLYCOPROTEIN MEDIATED DRUG EFFLUX
University of Missouri (U.S. Pat. No. 7,553,812): ACYCLOVIR-PEPTIDE ANALOGS
Hybritech Inc. (U.S. Pat. No. 6,103,237); STABLE VARIANT HK2 POLYPEPTIDE
Mayo Clinic (U.S. Patent No. 5,583,108): VASONATRIN PEPTIDE
Mayo Clinic/Hybritech, Inc. (U.S. Pat. No. 6,093,796): RECOMBINANT HK2 POLYPEPTIDE
U of Minnesota (U.S. Patent No. 5,523,286): A STROMA-DERIVED PROTEOGLYCAN CONTAINING COMPOSITION WHICH PROMOTES DIFFERENTIATION AND MAINTAINS THE SELF-RENEWAL CAPACITY OF LONG-TERM BONE MARROW CULTURE-INITIATING CELLS
U of Minnesota (U.S. Pat. No. 5,424,221): KIT FOR DETECTION OF ISLET AMYLOID POLYPEPTIDE (IAPP)
U of Minnesota (U.S. Pat. No. 5,019,646): POLYPEPTIDES WITH FIBRONECTIN ACTIVITY
U of Minnesota (U.S. Pat. No. 5,158,884): IMMUNODOMINANT ACETYCHOLINE RECEPTOR PEPTIDES
Mayo Clinic (U.S. Patent No. 5,260,308): METHOD TO INCREASE PERMEABILITY OF THE BLOOD-NERVE/BRAIN BARRIERS TO PROTEINS
Agricultural Biotechnology
APC Company, Inc. (U.S. Pat. No. 7,182,962): IMMUNOSTIMULATOR FOR ANIMALS
The Lauridsen Group (U.S. Pat. No. 7,258,870): POULTRY FEED SUPPLEMENT
DEKALB Genetics Corp. (U.S. Pat. No. 6,025,545): METHODS AND COMPOSITIONS FOR THE PRODUCTION OF STABLY TRANSFORMED, FERTILE MONOCOT PLANTS
DEKALB Genetics Corp. (U.S. Pat. No. 6,013,863): FERTILE TRANSGENIC CORN PLANTS
DEKALB Genetics Corp. (U.S. Pat. No. 5,538,880): METHOD FOR PREPARING FERTILE TRANSGENIC CORN PLANTS
DEKALB Genetics Corp. (U.S. Pat. No. 5,538,877): METHOD FOR PREPARING FERTILE TRANSGENIC CORN PLANTS
DEKALB Genetics Corp. (U.S. Pat. No. 5,484,956): FERTILE TRANSGENIC ZEA MAYS PLANT COMPRISING HETEROLOGOUS DNA ENCODING BACILLUS THURINGIENSIS ENDOTOXIN
DEKALB Genetics Corp. (U.S. Pat. No. 5,554,798): FERTILE GLYPHOSATE-RESISTANT TRANSGENIC CORN PLANTS
University of Minnesota (U.S. Pat. Nos. 6,069,298; 6,146,861; 6,222,099): METHODS AND AN ACETYL COA CARBOXYLASE GENE
Methods of Medical Treatment
University of Virginia (U.S. Pat. No. 7,442,681): METHOD OF INHIBITING VASCULAR PERMEABILITY
Eisai Inc. (U.S. Pat. No. 7,709,529): IMPROVED TREATMENT OF CANCER WITH GLUTAMINE
CUNY (U.S. Pat. No. 6,461,609: RECOMBINANT a-GAL-A; A THERAPY FOR FABRY DISEASE
NeoRx (U.S. Pat. Nos. 5,770,609; 5,945,456; 6,197,789; 6,251,920; 6,262,079): PREVENTION AND TREATMENT OF PATHOLOGIES ASSOCIATED WITH ABNORMALLY PROLIFERATIVE SMOOTH MUSCLE CELLS
NeoRx (U.S. Pat. Nos. 5,811,447; 5,733,925; 6,074,659): THERAPEUTIC INHIBITOR OF VASCULAR SMOOTH MUSCLE CELLS
Mayo Clinic (U.S. Pat. No. 5,837,713): TREATMENT OF EOSINOPHIL-ASSOCIATED PATHOLOGIES
University of Minnesota (U.S. Pat No. 5,780,479): USE OF OPIOID ANTAGONISTS TO TREAT IMPULSE CONTROL DISORDERS
Mayo Clinic (U.S. Pat. No. 5,691,343): USE OF TOPICAL AZATHIOPRENE TO TREAT INFLAMMATORY BOWEL DISORDERS
Mayo Clinic (U.S. Pat. No. 5,510,339): METHOD FOR TREATMENT OF BRONCHIAL ASTHMA BY ADMINISTRATION OF TOPICAL ANESTHETICS
Center for Innovative Technology (U.S. Pat. No. 5,541,226): TOPICAL COMPOSITIONS FOR RE-EPITHELIALIZATION OF PERSISTENT EPITHELIAL DEFECTS
Gleich (U.S. Pat. No. 5,498,410): METHOD FOR THE TREATMENT OF EOSINOPHIL-ASSOCIATED CONDITIONS WITH ANIONIC POLYMERS
NeoRx (U.S. Pat. No. 5,472,985): PREVENTION AND TREATMENT OF PATHOLOGIES ASSOCIATED WITH ABNORMALLY PROLIFERATIVE SMOOTH MUSCLE CELLS
U of Minnesota (U.S. Pat. No. 5,411,965): USE OF DELTA OPIOID RECEPTOR ANTAGONISTS TO TREAT COCAINE ABUSE
Drug Delivery Systems
Iowa State University (U.S. Pat. No. 7563,451): CAPPED MESOPOROUS SILICATES
Rutgers (U.S. Pat. No. 5,560,922): TRANSDERMAL ABSORPTION DOSAGE UNIT USING A POLYACRYLATE ADHESIVE POLYMER AND PROCESS
U.S. Pat. No. 4,708,834: PREPARATION OF GELATIN-ENCAPSULATED CONTROLLED RELEASE COMPOSITION
U.S. Pat. No. 5,368,581: METHOD FOR USING A PACKAGING SYSTEM WITH FOLDED APPLICATOR PADS FOR DRUG DELIVERY
Medical Devices
U.S. Pat. No. 4,619,657: FLEXIBLE INTRAOCULAR LENS HOLDER
U.S. Pat. No. 5,073,171: BIOCOMPATIBLE MATERIALS COMPRISING ALBUMIN-BINDING DYES
U.S. Pat. No. 5,152,784: PROSTHETIC DEVICES COATED WITH A POLYPEPTIDE WITH TYPE IV COLLAGEN ACTIVITY
DNA Isolation and Synthesis
U.S. Pat. No. 5,023,171: METHOD FOR GENE SPLICING BY OVERLAP EXTENSION USING PCR
U.S. Pat. No. 5,243,039: BACILLUS MGA3 ASPARTOKINASE II GENE
Vaccines
Endobiologics, Inc. (U.S. Pat. No. 7,014,857): ANTI-SEPSIS CONJUGATE VACCINE
Mikrogen (U.S. Pat. No. 6,183,755): ACTIVE PROTEINS FROM B. BURGDORFERI
Iowa State University (U.S. Pat. No. 5,419,907): PATHOGENIC PORCINE RESPIRATORY CORONAVIRUS
University of Minnesota (U.S. Pat. No. 4,721,617): VACCINE AGAINST LYME DISEASE
University of Minnesota (U.S. Pat. No. 5,843,462): DIPHTHERIA TOXIN EPITOPES